The Effect of Interleukin-1 Receptor Antagonist on Insulin Secretion in Subjects With Beta Cell Dysfunction.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 27 Sep 2013
At a glance
- Drugs Anakinra (Primary)
- Indications Glucose intolerance
- Focus Therapeutic Use
- 27 Sep 2013 Results presented at the 49th Annual Meeting of the European Association for the Study of Diabetes.
- 26 Sep 2013 Primary endpoint 'Insulin-levels' has been met.
- 23 Mar 2012 Planned End Date changed from 1 Dec 2011 to 1 Dec 2012 as reported by ClinicalTrials.gov.